Table 3 Univariate Cox analysis of prognostic association of all 24 CC-Chemokine’s expression on metastatic relapse in BrCa based on the bc-GenExMiner v4.1 DNA gene chip database.

From: CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival

Chemokine

p value

HR

95% CI

CCL1

0.4894

0.98

0.92–1.04

CCL2

0.6384

1.01

0.96–1.08

CCL3

0.0785

0.91

0.83–1.01

CCL4

0.0038

0.91

0.86–0.97

CCL5

0.0335

0.94

0.88–0.99

CCL7

0.173

1.05

0.98–1.11

CCL8

0.0017

1.1

1.04–1.17

CCL11

0.4707

0.98

0.92–1.04

CCL13

0.9444

1

0.93–1.07

CCL14

0.5541

0.94

0.76–1.15

CCL15

0.1379

1.2

0.94–1.52

CCL16

0.6384

1.01

0.96–1.08

CCL17

0.8037

0.99

0.93–1.06

CCL18

0.6961

1.01

0.95–1.08

CCL19

0.001

0.9

0.85–0.96

CCL20

0.8989

1

0.94–1.07

CCL21

<0.0001

0.88

0.82–0.93

CCL22

<0.0001

0.87

0.82–0.93

CCL23

0.0014

0.88

0.81–0.95

CCL24

0.9997

1

0.94–1.07

CCL25

0.1064

1.05

0.99–1.12

  1. HR-Hazard ratio. 95% CI- confidence interval. Bold represents a p value of ≤0.04.